Soufflé Therapeutics

Soufflé Therapeutics is a biotechnology company developing cell-specific small interfering RNA (siRNA) medicines for a range of diseases

Biotech & Life Sciences

Sector

Seed

Stage

B2B

Model

01Company Overview

Soufflé Therapeutics is a biotechnology company developing cell-specific small interfering RNA (siRNA) medicines for a range of diseases.

02Backed By1 investor

03Recent Activity

FROM Leaps by Bayer

Bayer and Soufflé Therapeutics announced a strategic collaboration to advance cell-specific heart-targeted siRNA therapy.

MILESTONE·leaps.bayer.com

JAN 8, 2026

04Similar Companies

TT

MB

KP

B

AP

05Startup DNA

11

signals

Sectors
Business Model
Technology